Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Silvestri

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2019
Standardization of nasal cytologic testing in the workup of allergic rhinitisGiorgio Ciprandi, Michela Silvestri
Italian Journal of Pediatrics|October 5, 2013
Melatonin: its possible role in the management of viral infections--a brief reviewMichela Silvestri, Giovanni A Rossi
International Forum of Allergy & Rhinology|May 26, 2017
Defining a diagnostic marker: a pragmatic requirementGiorgio Ciprandi, Michela Silvestri, Angela Pistorio
The Journal of Allergy and Clinical Immunology|February 8, 2006
Bronchial obstruction: a limited, out-of-fashion approach to measure treatment efficacy in childhood asthma?Michela Silvestri, Simona Bellodi, Giovanni A Rossi
Lung India : Official Organ of Indian Chest Society|January 4, 2019
Visual analog scale for assessing the perception of short-acting β2-agonist use in clinical practiceGiorgio Ciprandi, Michela Silvestri, Maria Angela Tosca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2018
A combination visual analog scale as an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practiceGiorgio Ciprandi, Michela Silvestri, Maria Angela Tosca
The Journal of Pediatrics|June 18, 2019
More on the impact of American Academy of Pediatrics palivizumab guidance for infants with respiratory syncytial virus infectionMichela Silvestri, Oliviero Sacco, Giovanni A Rossi
Expert Review of Clinical Immunology|December 19, 2013
Measuring the perception of symptom, drug use and allergen immunotherapy efficacy using the Visual Analogue ScaleGiorgio Ciprandi, Maria Angela Tosca, Michela Silvestri
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 21, 2009
Respiratory syncytial virus risk factors in late preterm infantsMarcello Lanari, Michela Silvestri, Giovanni A Rossi
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 11, 2010
Palivizumab prophylaxis in 'late preterm' newbornsMarcello Lanari, Michela Silvestri, Giovanni A Rossi
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 18, 2019
Standardization of nasal cytologic testing in the workup of allergic rhinitisGiorgio Ciprandi, Michela Silvestri
Italian Journal of Pediatrics|October 5, 2013
Melatonin: its possible role in the management of viral infections--a brief reviewMichela Silvestri, Giovanni A Rossi
International Forum of Allergy & Rhinology|May 26, 2017
Defining a diagnostic marker: a pragmatic requirementGiorgio Ciprandi, Michela Silvestri, Angela Pistorio
The Journal of Allergy and Clinical Immunology|February 8, 2006
Bronchial obstruction: a limited, out-of-fashion approach to measure treatment efficacy in childhood asthma?Michela Silvestri, Simona Bellodi, Giovanni A Rossi
Lung India : Official Organ of Indian Chest Society|January 4, 2019
Visual analog scale for assessing the perception of short-acting β2-agonist use in clinical practiceGiorgio Ciprandi, Michela Silvestri, Maria Angela Tosca
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2018
A combination visual analog scale as an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practiceGiorgio Ciprandi, Michela Silvestri, Maria Angela Tosca
The Journal of Pediatrics|June 18, 2019
More on the impact of American Academy of Pediatrics palivizumab guidance for infants with respiratory syncytial virus infectionMichela Silvestri, Oliviero Sacco, Giovanni A Rossi
Expert Review of Clinical Immunology|December 19, 2013
Measuring the perception of symptom, drug use and allergen immunotherapy efficacy using the Visual Analogue ScaleGiorgio Ciprandi, Maria Angela Tosca, Michela Silvestri
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|November 21, 2009
Respiratory syncytial virus risk factors in late preterm infantsMarcello Lanari, Michela Silvestri, Giovanni A Rossi
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 11, 2010
Palivizumab prophylaxis in 'late preterm' newbornsMarcello Lanari, Michela Silvestri, Giovanni A Rossi
Pageof 9